- Filed
- Dec 13, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Dec 9, 2024 | 6.97M sh |
| Cash And Equivalents | Q2 2025 · Oct 31, 2024 | $20.84M |
| Cash And Equivalents | Q2 2025 · Apr 30, 2024 | $50.18M |
| Current Liabilities | Q2 2025 · Oct 31, 2024 | $4.78M |
| Current Liabilities | Q2 2025 · Apr 30, 2024 | $7.42M |
| Total Liabilities | Q2 2025 · Oct 31, 2024 | $11.65M |
| Total Liabilities | Q2 2025 · Apr 30, 2024 | $20.39M |
| Current Assets | Q2 2025 · Oct 31, 2024 | $21.33M |
| Current Assets | Q2 2025 · Apr 30, 2024 | $50.44M |
| Total Assets | Q2 2025 · Oct 31, 2024 | $55.1M |
| Total Assets | Q2 2025 · Apr 30, 2024 | $59.9M |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 8.77M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 10.68M sh |
| Stock Repurchased | Q2 2025 · Oct 31, 2023 | $26.62M |
| Operating Cash Flow | Q2 2025 · Oct 31, 2023 | −$1.64M |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | $36.77M |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | $39.19M |
| Stockholders Equity | Q2 2025 · Apr 30, 2023 | $72.69M |
| Eps Diluted | Q2 2025 · Oct 31, 2023 | −$0.26 |
| Eps Diluted | Q2 2025 · Oct 31, 2023 | −$0.85 |
| Eps Basic | Q2 2025 · Oct 31, 2023 | −$0.26 |
| Eps Basic | Q2 2025 · Oct 31, 2023 | −$0.85 |
| Rd Expense | Q2 2025 · Oct 31, 2023 | $82.03K |
| Rd Expense | Q2 2025 · Oct 31, 2023 | $186.52K |
| Net Income | Q2 2025 · Oct 31, 2023 | $2.79M |
| Net Income | Q2 2025 · Oct 31, 2023 | −$393.4K |
| Net Income | Q2 2025 · Jul 31, 2023 | −$3.18M |
| Operating Income | Q2 2025 · Oct 31, 2023 | −$1.41M |
| Operating Income | Q2 2025 · Oct 31, 2023 | −$3.48M |
| Revenue | Q2 2025 · Oct 31, 2023 | $0 |
| Revenue | Q2 2025 · Oct 31, 2023 | $0 |